Skip to main content

Table 1 Ratios used to estimate the incidence of cases of non-invasive infections, France 2012

From: Estimating the morbidity and mortality associated with infections due to multidrug-resistant bacteria (MDRB), France, 2012

Body sites

PPS ratio

Ratios from the literature

Low value

High value

No. MRSA urinary tract infections/No. MRSA invasive infections

0.98 [7]

0.75 [11]

2.30 [12]

No. MRSA respiratory infections/No. MRSA invasive infections

2.37 [7]

1.25 [11]

2.50 [12]

No. MRSA skin and soft tissue infections and surgical site infections/No. MRSA invasive infections

4.17 [7]

4.90 [12]

5.25 [11]

No. MRSA bone and joint infections/No. MRSA invasive infections

0.79 [7]

b

1.38 [12]

No. GRE urinary tract infections/No. GRE invasive infections

4.33 [7]

2.33 [13]

3.44 [14]

No. GRE gastrointestinal tract infections /No. GRE invasive infections

2.65 [7]

1.89 [14]

b

No. GRE skin and soft tissue infections and surgical site infections/No. GRE invasive infections

1.46 [7]

4.67 [14]

5.00 [13]

No. 3GC-R E. coli urinary tract infections/No. 3GC-R E. coli invasive infections

5.50 [7]

2.30 [13]

b

No. 3GC-R E. coli respiratory tract infections/No. 3GC-R E. coli invasive infections

1.08 [7]

b

2.50 [13]

No. 3GC-R E. coli skin and soft tissue infections and surgical site infections/No. 3GC-R E. coli invasive infections

1.37 [7]

b

4.90 [13]

No. 3GC-R K. pneumoniae urinary tract infections/No. 3GC-R K. pneumoniae invasive infections

2.90 [7]

1.19 [15]

2.30 [13]

No. 3GC-R K. pneumoniae respiratory tract infections/No. 3GC-R K. pneumoniae invasive infections

2.55 [7]

1.19 [15]

2.50 [13]

No. 3GC-R K. pneumoniae skin and soft tissue infections and surgical site infections/No. 3GC-R K. pneumoniae invasive infections

0.82 [7]

0.33 [15]

4.90 [13]

No. CR K. pneumoniae urinary tract infections/No. CR K. pneumoniae invasive infections

2.71 [7]

3.00 [16]

3.10 [17]

No. CR K. pneumoniae respiratory tract infections/No. CR K. pneumoniae invasive infections

3.10 [7]

0.42 [17]

1.60 [16]

No. CR K. pneumoniae skin and soft tissue infections and surgical site infections/No. CR K. pneumoniae invasive infections

0.44a

0.28 [17]

0.60 [16]

No. CR P. aeruginosa urinary tract infections/No. CR P. aeruginosa invasive infections

2.11 [7]

b

11.30 [15]

No. CR P. aeruginosa respiratory tract infections/No. CR P. aeruginosa invasive infections

10.99 [7]

b

16.00 [15]

No. CR P. aeruginosa skin and soft tissue infections and surgical site infections/No. CR P. aeruginosa invasive infections

3.07 [7]

b

4.67 [15]

No. CR Acinetobacter urinary tract infections/No. CR Acinetobacter invasive infections

0.58a

0.32 [18]

0.83 [17]

No. CR Acinetobacter respiratory tract infections/No. CR Acinetobacter invasive infections

4.64 [7]

1.21 [18]

3.83 [17]

No. CR Acinetobacter skin and soft tissue infections and surgical site infections/No. CR Acinetobacter invasive infections

0.73a

0.29 [18]

1.17 [17]

  1. ano 2012 PPS data for these infections because the prevalence of these MDRB is too low in France; the ratio value applied is the mean value of the 2 ratios from the literature
  2. bno data in the literature for these infections; the value of the 2012 PPS ratio was applied